IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $326,987 | +5.1% | 6,972 | -5.4% | 0.11% | +3.8% |
Q2 2023 | $311,025 | -55.1% | 7,372 | -62.0% | 0.11% | -57.1% |
Q1 2023 | $692,045 | -9.3% | 19,385 | 0.0% | 0.25% | -27.6% |
Q4 2022 | $763,381 | -15.7% | 19,385 | -2.5% | 0.34% | -25.4% |
Q3 2022 | $906,000 | +58.1% | 19,885 | +27.5% | 0.46% | +56.5% |
Q2 2022 | $573,000 | -10.3% | 15,593 | 0.0% | 0.29% | -0.7% |
Q1 2022 | $639,000 | +37.1% | 15,593 | 0.0% | 0.29% | +54.7% |
Q4 2021 | $466,000 | -14.3% | 15,593 | 0.0% | 0.19% | +2.2% |
Q3 2021 | $544,000 | -10.2% | 15,593 | 0.0% | 0.19% | -16.2% |
Q2 2021 | $606,000 | -8.5% | 15,593 | 0.0% | 0.22% | -16.9% |
Q1 2021 | $662,000 | -27.9% | 15,593 | +4.9% | 0.27% | -30.1% |
Q4 2020 | $918,000 | +1.5% | 14,863 | -2.6% | 0.38% | -27.9% |
Q2 2020 | $904,000 | +16.2% | 15,263 | +2.7% | 0.53% | -21.0% |
Q1 2020 | $778,000 | -13.2% | 14,863 | 0.0% | 0.67% | -16.9% |
Q4 2019 | $896,000 | +6.4% | 14,863 | 0.0% | 0.81% | -7.7% |
Q3 2019 | $842,000 | +84100.0% | 14,863 | 0.0% | 0.87% | +1932.6% |
Q1 2019 | $1,000 | – | 14,863 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |